cookie

We use cookies to improve your browsing experience. By clicking «Accept all», you agree to the use of cookies.

avatar

CNBC

First in business worldwide. Contact: @GlobalManagementBot

Show more
Advertising posts
752
Subscribers
No data24 hours
No data7 days
No data30 days

Data loading in progress...

Subscriber growth rate

Data loading in progress...

Photo unavailableShow in Telegram
How U.S. microchips are fueling Russia's military — despite sanctions Moscow is sourcing a growing number of advanced microchips from the West through intermediary countries such as China, analysis by CNBC shows.
Show all...
Read full story
Photo unavailableShow in Telegram
Red Cross ends blood-donation restrictions that singled out gay and bisexual men The FDA in May dropped a nearly 40-year policy that had singled out men who have sex with men.
Show all...
Read full story
Photo unavailableShow in Telegram
We're starting a position in a recently added Bullpen stock for three main reasons One of the reasons: The company has become an industrial way to play the recovery in the semiconductors.
Show all...
Read full story
Photo unavailableShow in Telegram
Zoom can now train its A.I. using some customer data, according to updated terms Zoom's update comes amid growing public debate on the extent to which AI services should be trained on individuals' data.
Show all...
Read full story
Photo unavailableShow in Telegram
Harvard expert: Use this formula to improve your life satisfaction and your relationship with money To have a "truly rich life," it's important to build emotional wealth as well as financial health, says author Manisha Thakor. Here's how to do it.
Show all...
Read full story
Photo unavailableShow in Telegram
The 10 most in-demand summer vacation destinations in the United States—3 are in Florida HomeToGo ranked the most popular U.S. summer destinations based on growth in travelers searching for stays between July 1 and August 31, 2023.
Show all...
Read full story
Photo unavailableShow in Telegram
Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug The FDA approved the pill zuranolone, developed by Sage and Biogen, for postpartum depression but declined to approve it for major depressive disorder.
Show all...
Read full story
Photo unavailableShow in Telegram
Warren Buffett's protégé was hired after sending the billionaire a letter—but it wasn't just luck Tracy Britt Cool was hired at Berkshire straight out of business school after she wrote a letter to Warren Buffett. It wasn't the only letter she sent.
Show all...
Read full story
Photo unavailableShow in Telegram
Siemens Energy CEO on $2.4 billion wind turbine hit: We were 'going too fast' with new products Siemens Energy has booked 2.2 billion euros ($2.4 billion) in costs due to quality issues at its wind turbine unit.
Show all...
Read full story
Photo unavailableShow in Telegram
The deadline for a ruling on Ark's application for a bitcoin ETF is near The SEC is required to give a thumbs up or thumbs down to ARK's application for a bitcoin ETF by Aug. 13.
Show all...
Read full story
Choose a Different Plan

Your current plan allows analytics for only 5 channels. To get more, please choose a different plan.